Yamakawa, H.; Toyoda, Y.; Baba, T.; Kishaba, T.; Fukuda, T.; Takemura, T.; Kuwano, K.
Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review. J. Clin. Med. 2022, 11, 3835.
https://doi.org/10.3390/jcm11133835
AMA Style
Yamakawa H, Toyoda Y, Baba T, Kishaba T, Fukuda T, Takemura T, Kuwano K.
Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review. Journal of Clinical Medicine. 2022; 11(13):3835.
https://doi.org/10.3390/jcm11133835
Chicago/Turabian Style
Yamakawa, Hideaki, Yuko Toyoda, Tomohisa Baba, Tomoo Kishaba, Taiki Fukuda, Tamiko Takemura, and Kazuyoshi Kuwano.
2022. "Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review" Journal of Clinical Medicine 11, no. 13: 3835.
https://doi.org/10.3390/jcm11133835
APA Style
Yamakawa, H., Toyoda, Y., Baba, T., Kishaba, T., Fukuda, T., Takemura, T., & Kuwano, K.
(2022). Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review. Journal of Clinical Medicine, 11(13), 3835.
https://doi.org/10.3390/jcm11133835